On-Sale Bar Applies In Angiomax Dispute, Fed. Circ. Told
Hospira Inc. has urged the full Federal Circuit to overrule a trial court and find that the on-sale bar, which prohibits patents on inventions that were on sale a year before...To view the full article, register now.
Already a subscriber? Click here to view full article